DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wang C, Sun JH, O'Boyle II DR. , et al.
Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir.
Antimicrob Agents Chemother 2013;
57 (05) 2054-2065
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.